EMP2 and cervical carcinoma: Based on previously described biological effects and expression levels in our study, NRAS 23 and EMP2 24 are predicted to increase cervical cancer cells apoptosis, while HIPK3 25, DKK1 26, THG1L 19 should decrease apoptosis.